Ran‐Ran Ma
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 12
- Circular RNAs in diseases 6
- RNA Research and Splicing 4
- Cancer-related gene regulation 3
-
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 4
- Co-authors
- Peng Gao (23 shared papers)Haiting Liu (16 shared papers)Hui Zhang (8 shared papers)Guo‐Hao Zhang (9 shared papers)Sen Liu (2 shared papers)Xiangyu Guo (5 shared papers)Lei Liu (1 shared paper)Wenjie Zhu (6 shared papers)
- Journals
- Oncogene (4 papers)Frontiers in Oncology (4 papers)Oncotarget (3 papers)Cell Death and Disease (3 papers)Advanced Healthcare Materials (1 paper)
- Partner nations
- ChinaCanadaSouth Korea
In The Last Decade
Ran‐Ran Ma
37 papers receiving 999 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 519
- Molecular Biology 645
- Oncology 105
- Immunology 64
- Pathology and Forensic Medicine 45
Countries citing papers authored by Ran‐Ran Ma
This map shows the geographic impact of Ran‐Ran Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran‐Ran Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran‐Ran Ma more than expected).
Fields of papers citing papers by Ran‐Ran Ma
This network shows the impact of papers produced by Ran‐Ran Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran‐Ran Ma. The network helps show where Ran‐Ran Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran‐Ran Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 152 | |
| 2 | 2021 | 147 | |
| 3 | 2015 | 77 | |
| 4 | 2020 | 61 | |
| 5 | 2019 | 58 | |
| 6 | 2023 | 48 | |
| 7 | 2015 | 48 | |
| 8 | 2020 | 47 | |
| 9 | 2019 | 32 | |
| 10 | 2017 | 29 | |
| 11 | 2020 | 26 | |
| 12 | 2020 | 23 | |
| 13 | 2021 | 23 | |
| 14 | 2019 | 21 | |
| 15 | 2021 | 19 | |
| 16 | 2017 | 19 | |
| 17 | 2019 | 19 | |
| 18 | 2021 | 18 | |
| 19 | 2022 | 16 | |
| 20 | 2021 | 14 |
About Ran‐Ran Ma
Ran‐Ran Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pathology and Forensic Medicine, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (12 papers), Circular RNAs in diseases (6 papers), RNA Research and Splicing (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related gene regulation (3 papers), Microtubule and mitosis dynamics (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (519 citations), Molecular Biology (645 citations), Oncology (105 citations), Immunology (64 citations) and Pathology and Forensic Medicine (45 citations). Ran‐Ran Ma has collaborated with scholars based in China, Canada and South Korea. Frequent co-authors include Peng Gao, Haiting Liu, Hui Zhang, Guo‐Hao Zhang, Sen Liu, Xiangyu Guo, Lei Liu, Wenjie Zhu, Duan‐Bo Shi and Yongxin Zou. Their work appears in journals such as Oncogene, Frontiers in Oncology, Oncotarget, Cell Death and Disease and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.